PLAT
Tissue-type plasminogen activator
As of the edition of 20 October 2026, PLAT (tissue-type plasminogen activator, UniProt P00750) has 1 drug tested at it and 4 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P00750
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Secreted
- Solved structures
- 11
- Disease areas
- Bones, joints and muscles; Heart and blood vessels; Inherited and neonatal; Blood and lymph; Cancer; Infections; Nervous system
- Registered trials of its drugs
- 16
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Aminocaproic acid | Marketed | Phase 4 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 4 |
| Total on the list | 4 |